塞力斯医疗科技集团股份有限公司关于收到中国证券监督管理委员会湖北监管局《行政处罚事先告知书》的公告

Core Viewpoint - The company, Selys Medical Technology Group Co., Ltd., has received an administrative penalty notice from the Hubei Regulatory Bureau of the China Securities Regulatory Commission (CSRC) due to violations related to information disclosure and related party transactions. Group 1: Administrative Penalty Details - The company and its actual controller, Wen Wei, are under investigation for failing to disclose related party transactions and the occupation of funds by major shareholders [2][3][4] - From 2020 to the first half of 2022, the actual controller arranged for the company to transfer funds to a related party, constituting a violation of disclosure obligations [3][6] - The total amount of funds occupied during this period was approximately 1.213 billion yuan in 2020, 1.3225 billion yuan in 2021, and 1.1465 billion yuan in the first half of 2022, with the amounts representing 7.48%, 7.33%, and 6.58% of the company's audited net assets respectively [3][4] Group 2: Violations and Responsibilities - The company failed to follow the required procedures for related party transactions and did not disclose these transactions until April 2023 [4][5] - Wen Wei, as the chairman and actual controller, is identified as the main responsible person for the violations, along with other executives who also failed to ensure proper disclosure [6][7][8] - The company is facing a total fine of 600 million yuan for the violations, with specific penalties for Wen Wei and other executives ranging from 30 million to 550 million yuan [15][16][17] Group 3: Impact on Company Operations - The company stated that the violations do not trigger mandatory delisting conditions and that its operations remain normal as of the announcement date [18] - The company has expressed its commitment to improving internal governance and compliance to prevent future violations [18][22] - The company is required to submit a rectification report within 30 days of receiving the penalty notice, detailing measures taken to address the violations [22]

塞力斯医疗科技集团股份有限公司关于收到中国证券监督管理委员会湖北监管局《行政处罚事先告知书》的公告 - Reportify